Track Advagene Biopharma , Ltd.'s intangible assets ($7.9M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 6709.TWO shows a intangible assets of $7.9M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 6709.TWO's intangible assets is now $7.9M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Advagene Biopharma , Ltd. is outperforming or lagging.
Tracking 6709.TWO's intangible assets over time shows whether Advagene Biopharma , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $7.9M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this intangible assets page, Stockcircle has Advagene Biopharma , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $7.9M) with ownership activity and broader fundamentals.
Advagene Biopharma , Ltd.'s intangible assets is $7.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.